Evaluation of beta-thalassemia in the fetus through cffDNA with multiple polymorphisms as a haplotype in the beta-globin gene

Transfusion Clinique et Biologique - Tập 27 - Trang 243-252 - 2020
Nadia Mirzaei Gisomi1, Gholamreza Javadi1, Shohre Zare Karizi2, Mohammad Miryounesi3, Parvaneh Keshavarz4,5
1Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran
2Department of biology, faculty of biological sciences, Islamic Azad university, Varamin-Pishva Branch, Varamin, Iran
3Department of medical genetics, Shahid Beheshti university of medical sciences, Tehran, Iran
4Cellular and Molecular Research Center, Faculty of Medicine, Guilan University of Medical Sciences, Rasht, Iran
5Medical genetics laboratory, Rasht, Iran

Tài liệu tham khảo

Lo, 1997, Presence of fetal DNA in maternal plasma and serum, Lancet, 350, 485, 10.1016/S0140-6736(97)02174-0 Greeley, 2015, Clinical applications of noninvasive prenatal testing, J Fetal Med, 2, 11, 10.1007/s40556-015-0035-1 Lun, 2008, Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma, Clin Chem, 54, 1664, 10.1373/clinchem.2008.111385 Barrett, 2011, Implementing prenatal diagnosis based on cell-free fetal DNA: accurate identification of factors affecting fetal DNA yield, PloS One, 6, e25202, 10.1371/journal.pone.0025202 Sun, 2019, Circulating cell-free DNA Verhoef, 2016, Non-invasive prenatal diagnosis (NIPD) for single gene disorders: cost analysis of NIPD and invasive testing pathways, Prenat Diagn, 36, 636, 10.1002/pd.4832 Bustamante-Aragonés, 2012, Non-invasive prenatal diagnosis of single-gene disorders from maternal blood, Gene, 504, 144, 10.1016/j.gene.2012.04.045 Lench, 2013, The clinical implementation of non-invasive prenatal diagnosis for single-gene disorders: challenges and progress made, Prenat Diagn, 33, 555, 10.1002/pd.4124 Bustamante-Aragones, 2008, New strategy for the prenatal detection/exclusion of paternal cystic fibrosis mutations in maternal plasma, J Cyst Fibros, 7, 505, 10.1016/j.jcf.2008.05.006 Hill, 2015, Non-invasive prenatal diagnosis for cystic fibrosis: detection of paternal mutations, exploration of patient preferences and cost analysis, Prenat Diagn, 35, 950, 10.1002/pd.4585 Chitty, 2015, Non-invasive prenatal diagnosis of achondroplasia and thanatophoric dysplasia: next-generation sequencing allows for a safer, more accurate, and comprehensive approach, Prenat Diagn, 35, 656, 10.1002/pd.4583 Hui, 2017, Universal haplotype-based noninvasive prenatal testing for single gene diseases, Clin Chem, 63, 513, 10.1373/clinchem.2016.268375 Lo, 2010, Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus, Sci Transl Med, 2, 10.1126/scitranslmed.3001720 Lam, 2012, Noninvasive prenatal diagnosis of monogenic diseases by targeted massively parallel sequencing of maternal plasma: application to β-thalassemia, Clin Chem, 58, 1467, 10.1373/clinchem.2012.189589 New, 2014, Noninvasive prenatal diagnosis of congenital adrenal hyperplasia using cell-free fetal DNA in maternal plasma, J Clin Endocrinol Metab, 99, E1022, 10.1210/jc.2014-1118 Jenkins, 2018, Delivering an accredited non-invasive prenatal diagnosis service for monogenic disorders and recommendations for best practice, Prenat Diagn, 38, 44, 10.1002/pd.5197 Peng, 2017, Bioinformatics approaches for fetal DNA fraction estimation in noninvasive prenatal testing, Int J Molecular Sci, 18, 453, 10.3390/ijms18020453 Chiu, 2018, cfDNA screening and diagnosis of monogenic disorders – where are we heading?, Prenat Diagn, 38, 52, 10.1002/pd.5207 Wang, 1998, Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome, Science, 280, 1077, 10.1126/science.280.5366.1077 Collins, 1997, Variations on a theme: cataloging human DNA sequence variation, Science, 278, 1580, 10.1126/science.278.5343.1580 Cotton, 2018, The human genome and neonatal care, 180 Hashemi-Soteh, 2017, Haplotypes inside the beta-globin gene: use as new biomarkers for beta-thalassemia prenatal diagnosis in north of Iran, J Biomed Sci, 24, 92, 10.1186/s12929-017-0396-y Weatherall, 2010, Thalassemia as a global health problem: recent progress toward its control in the developing countries, Ann N Y Acad Sci, 1202, 17, 10.1111/j.1749-6632.2010.05546.x Ostrowsky, 1985, Cost-benefit analysis of a thalassemia disease prevention program, Am J Public Health, 75, 732, 10.2105/AJPH.75.7.732 Abolghasemi, 2007, Thalassemia in Iran: epidemiology, prevention, and management, J Pediatr Hematol Oncol, 29, 233, 10.1097/MPH.0b013e3180437e02 Bazi, 2016, Spectrum of β-thalassemia mutations in Iran, an update, Iran J Pediatr Hematol Oncol, 6, 190 O’Leary, 2013, Prenatal screening for Down syndrome in Australia: costs and benefits of current and novel screening strategies, Aust N Z J Obstet Gynaecol, 53, 425, 10.1111/ajo.12136 Tabor, 2010, Update on procedure-related risks for prenatal diagnosis techniques, Fetal Diagn Ther, 27, 1, 10.1159/000271995 Li, 2009, Size fractionation of cell-free DNA in maternal plasma improves the detection of a paternally inherited β-thalassemia point mutation by MALDI-TOF mass spectrometry, Fetal Diagn Ther, 25, 246, 10.1159/000223442 Rafati, 2015, Microfluidic method for rapid turbidimetric detection of the DNA of Mycobacterium tuberculosis using loop-mediated isothermal amplification in capillary tubes, Microchimica Acta, 182, 523, 10.1007/s00604-014-1354-y Akhavan-Niaki, 2012, Beta globin frameworks in Thalassemia major patients from North Iran, Iran J Pediatr, 22, 297 Chen, 2015, Non-invasive prenatal diagnosis using fetal DNA in maternal plasma: a preliminary study for identification of paternally-inherited alleles using single nucleotide polymorphisms, BMJ Open, 5, e007648, 10.1136/bmjopen-2015-007648 Huang, 2006, Improvement of methods for the isolation of cell-free fetal DNA from maternal plasma: comparison of a manual and an automated method, Ann N Y Acad Sci, 1075, 308, 10.1196/annals.1368.041 Huang, 2008, Isolation of cell-free DNA from maternal plasma using manual and automated systems, 203 Holmberg, 2013, Akonni TruTip® and Qiagen® methods for extraction of fetal circulating DNA-evaluation by real-time and digital PCR, PloS one, 8.8, e73068, 10.1371/journal.pone.0073068 Ramezanzadeh, 2016, Detection of paternally inherited fetal point mutations for β-thalassemia in maternal plasma using simple fetal DNA enrichment protocol with or without whole genome amplification: an accuracy assessment, J Mater Fetal Neonatal Med, 29, 2645 Parks, 2017, Non-invasive prenatal diagnosis of spinal muscular atrophy by relative haplotype dosage, Eur J Hum Genet, 25, 416, 10.1038/ejhg.2016.195 Parks, 2016, Non-invasive prenatal diagnosis of Duchenne and Becker muscular dystrophies by relative haplotype dosage, Prenat Diag, 36, 312, 10.1002/pd.4781 Vermeulen, 2017, Sensitive monogenic noninvasive prenatal diagnosis by targeted haplotyping, Am J Hum Genet, 101, 326, 10.1016/j.ajhg.2017.07.012 Ye, 2018, Haplotype-based noninvasive prenatal diagnosis of hyperphenylalaninemia through targeted sequencing of maternal plasma, Sci Rep, 8, 1 Bruno, 2011, Extending the scope of diagnostic chromosome analysis: detection of single gene defects using high-resolution SNP microarrays, Hum Mutat, 32, 1500, 10.1002/humu.21581 Pergament, 2014, Single-nucleotide polymorphism – based noninvasive prenatal screening in a high-risk and low-risk cohort, Obstet Gynecol, 124, 210, 10.1097/AOG.0000000000000363 Everett, 2015, Cell-free fetal DNA: the new tool in fetal medicine, Ultrasound Obstet Gynecol, 45, 499, 10.1002/uog.14746 Ding, 2004, MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis, Proc Natl Acad Sci, 101, 10762, 10.1073/pnas.0403962101 Darabi, 2018, An enrichment method of cell-free fetal DNA from mothers in the 11th week of pregnancy; on the way of non-invasive prenatal diagnosis of beta-thalassemia as a single gene disorder, J Sci Islamic Repub Iran, 29, 305 Zafari, 2016, High-resolution melting analysis for noninvasive prenatal diagnosis of IVS-II-I (GA) fetal DNA in minor beta-thalassemia mothers, J Mater Fetal Neonatal Med, 29, 3323